IDNA Among Health Care ETFs
End-of-day Nov 18, 2026 · 33 Health care ETFs by YTD
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.9% | −9.0% | −9.8% | −2.2% | +47.3% | +48.7% | +115.2% | −16.0% | — | +65.7% |
| Peer average | −0.9% | −5.3% | −1.4% | −2.4% | +17.0% | +21.8% | +68.8% | +23.4% | +169.9% | — |
| S&P 500 · VOO | −0.3% | −3.9% | −5.0% | −4.0% | +8.0% | +10.9% | +72.4% | +68.9% | +302.1% | — |
$131 of every $1,000 in IDNA is Moderna
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | MRNAModerna | Healthcare | 13.13% | $1,313.00 | 209K | $43.2M |
| 2 | GMAB.COGenmab | Healthcare | 6.30% | $630.20 | 40K | $20.7M |
| 3 | TWSTTwist Bioscience | Healthcare | 4.87% | $487.35 | 143K | $16.0M |
| 4 | REGNRegeneron Pharmaceuticals | Healthcare | 4.54% | $453.91 | 16K | $14.9M |
| 5 | BAYN.DEBayer AG | Healthcare | 4.45% | $445.47 | 237K | $14.7M |
| 6 | 4502.TTakeda Pharmaceutical | Healthcare | 4.26% | $425.83 | 322K | $14.0M |
| 7 | EXELExelixis | Healthcare | 3.91% | $391.30 | 188K | $12.9M |
| 8 | VRTXVertex Pharmaceuticals | Healthcare | 3.60% | $360.16 | 22K | $11.9M |
| 9 | MRKMerck | Healthcare | 3.58% | $357.64 | 82K | $11.8M |
| 10 | ROP.SWRoche PS PAR AG | Healthcare | 3.54% | $354.05 | 24K | $11.7M |
| 11 | INCYIncyte | Healthcare | 3.50% | $350.09 | 97K | $11.5M |
| 12 | RVMDRevolution Medicines | Healthcare | 3.28% | $328.39 | 66K | $10.8M |
| 13 | SAN.PASanofi | Healthcare | 3.19% | $318.70 | 110K | $10.5M |
| 14 | IPN.PAIpsen | Healthcare | 2.98% | $298.37 | 54K | $9.8M |
| 15 | BNTXBiontech SE | Healthcare | 2.90% | $290.37 | 113K | $9.6M |
of the $112B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | MRNA | Moderna | 13.13% |
| 2 | GMAB.CO | Genmab | 6.30% |
| 3 | TWST | Twist Bioscience | 4.87% |
| 4 | REGN | Regeneron Pharmaceuticals | 4.54% |
| 5 | BAYN.DE | Bayer AG | 4.45% |
| 6 | 4502.T | Takeda Pharmaceutical | 4.26% |
| 7 | EXEL | Exelixis | 3.91% |
| 8 | VRTX | Vertex Pharmaceuticals | 3.60% |
| 9 | MRK | Merck & | 3.58% |
| 10 | ROP.SW | Roche PS PAR AG | 3.54% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Jun 15, 2026 | Jun 18, 2026 | $0.13 |
| Dec 16, 2025 | Dec 19, 2025 | $0.16 |
| Jun 16, 2025 | Jun 20, 2025 | $0.15 |
| Dec 17, 2024 | Dec 20, 2024 | $0.11 |
| Jun 11, 2024 | Jun 17, 2024 | $0.11 |
| Dec 20, 2023 | Dec 27, 2023 | $0.17 |
| Jun 7, 2023 | Jun 13, 2023 | $0.0708 |
| Jun 9, 2022 | Jun 15, 2022 | $0.14 |
| Dec 13, 2021 | Dec 17, 2021 | $0.26 |
| Jun 10, 2021 | Jun 16, 2021 | $0.0520 |
| Dec 14, 2020 | Dec 18, 2020 | $0.0362 |
| Jun 15, 2020 | Jun 19, 2020 | $0.0837 |